Solid Biosciences Inc (SLDB)

[iluvkush]

It’s Actually A Kept BUY--Analyst Actions: Chardan Adjusts Solid Biosciences' PT to $12.50 From $5 After FDA Lifts Hold on SGT-001/DMD Trial; Buy Rating Kept
BY MT NEWSWIRES — 10:58 AM ET
10:58 AM EDT, 10/01/2020 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 4.52, Change: +2.49, Percent Change: +122.66

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2020 Midnight Trader, Inc. All rights reserved. https://www.benzinga.com/stock/SLDB/ratings